Shijian Zhang Selected Research

Shijian Zhang Research Topics

13	Infections 01/2023 - 10/2008
5	Virus Diseases (Viral Diseases) 01/2021 - 06/2012
4	Neoplasms (Cancer) 11/2023 - 12/2018
3	Squamous Cell Carcinoma of Head and Neck 01/2023 - 12/2018
3	COVID-19 01/2022 - 01/2021
3	Human Influenza (Influenza) 02/2013 - 11/2011
2	Fistula 06/2021 - 01/2020
1	Carcinogenesis 11/2023
1	Neurofibroma 11/2023
1	Carcinoma (Carcinomatosis) 01/2022
1	Shock 10/2021
1	Hepatitis C 02/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2013
1	Influenza in Birds (Avian Flu) 06/2012
1	Abscess 03/2011
1	Bacterial Infections (Bacterial Infection) 03/2011

6	Neutralizing AntibodiesIBA 11/2023 - 01/2021
6	VaccinesIBA 01/2023 - 02/2013
5	Glycoproteins (Glycoprotein)IBA 01/2023 - 08/2015
3	ciprofloxacin dithiocarbamateIBA 03/2011 - 10/2008
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2011
2	Amylases FDA Link 06/2021 - 01/2020
2	AntibodiesIBA 01/2020 - 08/2015
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 02/2013 - 06/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2023
1	p38 Mitogen-Activated Protein KinasesIBA 11/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	alectinibIBA 01/2022
1	CD4 Antigens (CD4 Antigen)IBA 11/2021
1	TungstenIBA 10/2021
1	COVID-19 VaccinesIBA 01/2021
1	PF 68742IBA 11/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Fluorescein (Funduscein)FDA LinkGeneric 02/2013
1	Antiviral Agents (Antivirals)IBA 02/2013
1	isothiocyanic acidIBA 02/2013
1	Tripartite Motif ProteinsIBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Caspase 3 (Caspase-3)IBA 06/2012
1	InterferonsIBA 06/2012
1	Human Immunodeficiency Virus tat Gene ProductsIBA 11/2011
1	Proline (L-Proline)FDA Link 11/2011
1	Peptides (Polypeptides)IBA 11/2011
1	norfloxacin dithiocarbamateIBA 03/2011
1	TurpentineIBA 03/2011
1	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2011

3	Therapeutics 01/2022 - 12/2018